Precision BioSciences Inc buy BMO Capital Markets
Start price
10.01.25
/
50%
€0.35
Target price
10.01.26
€33.15
Performance (%)
-
End price
11.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Precision BioSciences Inc | - | - | - |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Precision BioSciences Inc diskutieren
Precision BioSciences, Inc. (NASDAQ: DTIL) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $34.00 price target on the stock.
Ratings data for DTIL provided by MarketBeat
In the thread Trading Precision BioSciences Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten